Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia

G. Glodic (Zagreb, Croatia), I. Sabol (Zagreb, Croatia), L. Zmak (Zagreb, Croatia), A. Šola (Zagreb, Croatia), A. Marušic (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia), F. Džubur (Zagreb, Croatia), M. Jakopovic (Zagreb, Croatia), L. Kardum Bulat (Rijeka, Croatia), G. Pavliša (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), A. Civljak (Zagreb, Croatia), A. Dakic (Zagreb, Croatia), M. Jankovic Makek (Zagreb, Croatia)

Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Session: Extra-pulmonary tuberculosis and comorbidities
Session type: Thematic Poster
Number: 3002
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Glodic (Zagreb, Croatia), I. Sabol (Zagreb, Croatia), L. Zmak (Zagreb, Croatia), A. Šola (Zagreb, Croatia), A. Marušic (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia), F. Džubur (Zagreb, Croatia), M. Jakopovic (Zagreb, Croatia), L. Kardum Bulat (Rijeka, Croatia), G. Pavliša (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), A. Civljak (Zagreb, Croatia), A. Dakic (Zagreb, Croatia), M. Jankovic Makek (Zagreb, Croatia). Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia. 3002

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Invasive Mycobacterium avium intracellulare infection
Source: Eur Respir J 2006; 28: Suppl. 50, 312s
Year: 2006

Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections
Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Year: 2017


Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005



Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
Source: Eur Respir J 2013; 42: 454-460
Year: 2013



Mycobacterium xenopi pulmonary disease in Croatia
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017


Mycobacterium avium complex infection: phenotypes and outcomes
Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017
Year: 2017



Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS)
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001

The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi)
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017

In vitro susceptibility of M. avium against protionamide
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011

Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001

Characteristics of drug susceptibility of M. abscessus subsp. abscessus and M.chelonae
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009



Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Combined chemotherapy in Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 657s
Year: 2005